Clinical Trial Update: Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase trial tested metformin hydrochloride for effects on cytokines and exosomes in patients with head and neck cancers, including laryngeal, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Laryngeal Cancer
• Lip Cancer
• Oral Cavity Cancer
• Pharyngeal Cancer

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Larynx, Lip | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-11-20